Chloe Su, Ph.D.

Senior Biostatistician

Chloe Su earned her PhD in Epidemiology & Clinical Research at the Stanford University School of Medicine, and received her B.S. in Molecular, Cell and Developmental Biology with a Minor in Biomedical Research from UCLA. As someone with a family history of cancer, Chloe is passionate about improving early cancer detection and accelerating development of cancer treatments to improve the lives of cancer patients and their families, specifically through appropriate utilization of real-world data to complement randomized controlled trials. During her graduate training, she has worked with a variety of data types (clinical trial, EHR, registry and claims) to study the epidemiology of advanced lung cancer and evaluate surveillance strategies for second primary lung cancer. Prior to Stanford, Chloe was a clinical trial project and data manager at UCLA Health, where she managed studies in early lung cancer detection and led a team to curate data for an integrated EHR database for lung cancer. Chloehas also previously worked at ZS Associates and Genentech, Inc., using innovative trial designs and real-world evidence to accelerate clinical development in oncology. 

Clinical area of interest: Oncology, Women’s Health 

Methodology: Causal inference, real-world evidence, integrating real world evidence with randomized controlled trials

Selected Publications: 

  • Su CC, Wu JT, Neal JW, Popat RA, Kurian AW, Backhus LM, Nagpal S, Leung AN, Wakelee HA, and Han SS. Impact of Low-Dose Computed Tomography Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis. Journal of Thoracic Oncology. 2021;16(9):1479-1489. doi:10.1016/j.jtho.2021.05.010 
  • Su CC, Wu JT, Choi E, et al. Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non–Small Cell Lung Cancer. JAMA Network Open. 2023;6(9):e2335813. doi:10.1001/jamanetworkopen.2023.3581
  • Choi E*, Su CC*, Wu JT, Aredo JV, Neal JW, Leung AN, Backhus LM, Lui NS, Marchand LL, Stram DO, Liang SY, Cheng I, Wakelee H, Han SS. Second Primary Lung Cancer Among Lung Cancer Survivors Who Never Smoked. JAMA Network Open. 2023;6(11):e2343278-e2343278. doi:10.1001/jamanetworkopen.2023.43278
  • Wu JT, Corrigan J, Su CC, Dumontier C, La J, Khan A, Arya S, Sox-Harris A, Backhus LM, Das M, Do N, Brophy MT, Han SS, Kelley M, and Fillmore N. The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer Cancer Immunology, Immunotherapy. 2024;73(9):172. doi:10.1007/s00262-024-03763-w
  • Choi E, Luo SJ, Aredo JV, Backhus LM, Wilkens LR, Su CC, Neal JW, Marchand LL, Cheng I, Wakelee HA, and Han SS. The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer. JNCI Journal of National Cancer Institute. Published online December 10, 2021:djab224. doi:10.1093/jnci/djab224
  • Goins LM, Girard JR, Mondal BC, Buran S, Su CC, Tang R, Biswas T, Kissi JA, and Banerjee U. Wnt signaling couples G2 phase control with differentiation during hematopoiesis in Drosophila. Developmental Cell. 2024;0(0). doi:10.1016/j.devcel.2024.05.023
  • Evans CJ, Olson JM, Mondal BC,…,Su CC,…., and Banerjee U l. A functional genomics screen identifying blood cell development genes in Drosophila by undergraduates participating in a course-based research experience. G3 GenesGenomesGenetics. 2021;11(1):jkaa028. doi:10.1093/g3journal/jkaa028